Pfizer (PFE) spent up to $7.3 billion buying a biotech company most people have never heard of — and it may be its greatest move in years. Metsera, the firm Pfizer acquired, is modest yet ambitious.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results